ACBA Membership Benefits and Opportunities
The ACBA is poised to be a vigorous advocate and sophisticated ambassador in legal and regulatory venues across the country and in markets around the world, giving clinicians and their providers a voice in answer to any powerful market threat or monopolistic initiative. As the ACBA grows in membership, so will it grow in service to the members, their practices, and their business partners. If you own, use or service energy-based devices, we will be there to protect your business model. FIND OUT MORE about ACBA Membership opportunities.
I bought my Solta Fraxel thulium laser in 2012, fully expecting that as a customer and medical practitioner, I was being treated in good faith. Since I didn’t need the 1550 fractional module, I only bought only the thulium module.
The thulium laser has become one of our mainstays for treating photo-damage of the face, V-chest, hands, and extremities. It is part of our therapeutic armamentarium and it occupies a very specific niche in our center.
Recently I was informed that Solta would no longer sell tips as of January 2016 and would not service the unit after January 2017. Their reason was that there were only a small number of thulium stand-alone units in Solta’s base.
We are still paying for the unit. Had this forthcoming change in policy been disclosed upfront to me, I would have nixed the sale. I told Solta that their proposed solution to avoid the commercial damage they were about to knowingly inflict upon me (to upgrade to a combo box) was unacceptable. My arguments fell on deaf ears. Having destroyed the value of my first purchase, they insisted that I make another purchase. That is not the proper way to deal with a customer.
They should refund the depreciated residual value of the unit. I hoped that there would be some equity left in my device when I decided to sell it, but Solta has essentially sucked any value out of my unit unless I spend a substantial amount and upgrade to a combo unit that I neither want nor need.
Solta took this action unilaterally and without any regard to their obligations on behalf of their customers. They have been especially unsympathetic to my situation, particularly since their proposed solution – to the problem they chose to invent – is another large payment from me to them! Not only are they forcing me to eat the loss of equity, but I will lose the thulium from my practice.
I am truly shocked and dismayed by this move. I will never again deal with this company. If they did this to me, they will do it again to anyone else, because they feel there are no consequences.
It’s a shame that we, as practicing physicians who love our work, so often find ourselves with no voice and no recourse. We are at the mercy of companies that sell these devices to us.
Fortunately, some companies are very ethical in their business dealings. I hope the companies who treat us fairly will become very visible and known through the efforts of the ACBA.
Incidents like the one I experienced require us (as the base of end users) to have a collective and powerful voice, and to keep an advocate on our team who can level the playing field for us. As it stands now, we have very little if any recourse when situations like this arise. This needs to change, and it is finally about to happen with the ACBA.